Free BRCA Ovarian Cancer Drug Programme

To help BRCA gene mutation induced ovarian cancer patients, the Hong Kong Hereditary Breast Cancer Family Registry launched the Free BRCA Ovarian Cancer Drugs Programme to help disadvantaged families receive the most suitable medication.

All applicants should fulfill the below conditions:

Medical status:

Doctor prescription of programme drug as maintenance therapy

Sensitive to Platinum-based Chemotherapy

BRCA 1 or 2 positive

Relapsed High grade serous epithelial ovarian/fallopian tube/primary peritoneal cancer

Targeted service users:

Hong Kong Identity Card holder

Patients under Hong Kong Hospital Authority

With prescription issued by the Hong Kong Hospital Authority

Financial conditions: Applicants should have a monthly household income of less than HK$ 20,000

*Quotas of the programme will be filled on a first-come-first-served basis

For more information, please consult your doctor.

Promotion campaign of the programme is supported by The ONE logo